![Nir Naor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nir Naor
Directeur/Membre du Conseil chez
BRAINSTORM CELL THERAPEUTICS INC.
Fortune : 31 465 $ au 30/06/2026
Profil
Nir Naor is an Independent Director at Brainstorm Cell Therapeutics, Inc. since 2023.
Former positions include Chief Financial Officer at Axogen, Inc. from 2023 to 2025, Chief Financial Officer at QuVa Pharma, Inc. in 2023, Chief Financial Officer at HMNC Holding GmbH from 2021 to 2022, Chief Financial Officer at Arbor Pharmaceuticals, Inc. in 2021, Chief Financial Officer-US Americas at Molnlycke Health Care US LLC from 2017 to 2021, Chief Financial Officer-United States at UCB SA from 2012 to 2017, and Auditor at KPMG Corporate Finance LLC from 2001 to 2005.
Education includes undergraduate, graduate, and MBA degrees from Tel-Aviv University, a graduate degree from the University of Hamburg, and an MBA from the International Institute for Management Development.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/02/2026 | 31 465 ( 0,29 % ) | 31 465 $ | 30/06/2026 |
Postes actifs de Nir Naor
| Sociétés | Poste | Début |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur/Membre du Conseil | 20/06/2023 |
Anciens postes connus de Nir Naor
| Sociétés | Poste | Fin |
|---|---|---|
| AXOGEN, INC. | Directeur Financier/CFO | 11/05/2025 |
QuVa Pharma, Inc.
 QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Directeur Financier/CFO | 01/09/2023 |
HMNC Holding GmbH
 HMNC Holding GmbH Financial ConglomeratesFinance Provides investment services | Directeur Financier/CFO | 01/10/2022 |
Arbor Pharmaceuticals, Inc.
 Arbor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on neuroscience, cardiovascular and pediatric markets | Directeur Financier/CFO | 01/09/2021 |
Molnlycke Health Care US LLC
 Molnlycke Health Care US LLC Medical SpecialtiesHealth Technology Manufactures surgical and wound care products | Corporate Officer/Principal | 01/01/2021 |
Formation de Nir Naor
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
KPMG Corporate Finance LLC
 KPMG Corporate Finance LLC Investment ManagersFinance Provides investment advice | Finance |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hamburg
 University of Hamburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molnlycke Health Care US LLC
Molnlycke Health Care US LLC Medical SpecialtiesHealth Technology Manufactures surgical and wound care products | Health Technology |
Axogen, Inc.
 Axogen, Inc. Medical SpecialtiesHealth Technology Provides products and technologies for peripheral nerve reconstruction and regeneration | Health Technology |
QuVa Pharma, Inc.
QuVa Pharma, Inc. Medical SpecialtiesHealth Technology Manufactures sterile injectable products | Health Technology |
Arbor Pharmaceuticals, Inc.
Arbor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products which focuses on neuroscience, cardiovascular and pediatric markets | Health Technology |
HMNC Holding GmbH
HMNC Holding GmbH Financial ConglomeratesFinance Provides investment services | Finance |
Choisissez Zonebourse 
